Ignite Creation Date:
2024-05-06 @ 11:11 AM
Last Modification Date:
2024-10-26 @ 12:41 PM
Study NCT ID:
NCT03455764
Status:
COMPLETED
Last Update Posted:
2022-12-16
First Post:
2018-02-28
Brief Title:
MCS110 With BRAFMEK Inhibition in Patients With Melanoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute